Kunming Zhao

Kunming Zhao

Auto-generated profile, based on publicly available information

Kunming Zhao

School of Public Health, Qingdao University, Qingdao, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KZKunming Zhao
Kunming Zhao
XWXinyi Wang
Xinyi Wang
YJYaqiong Jin
Yaqiong Jin
XZXiaoxiao Zhu
Xiaoxiao Zhu
TZTao Zhou
Tao Zhou
DYDianke Yu
Dianke Yu
Neuroblastoma (NB) is a challenging pediatric extracranial solid tumor characterized by a poor prognosis and resistance to chemotherapy. Identifying targets to enhance chemotherapy sensitivity in NB is of utmost importance. Increasing evidence implicates long noncoding RNAs (lncRNAs) play important roles in cancer, but their functional roles remain largely unexplored. Here, we analyzed our RNA sequencing data and identified the upregulated lncRNA ZNF674-AS1 in chemotherapy non-responsive NB patients. Elevated ZNF674-AS1 expression is associated with poor prognosis and high-risk NB. Importantly, targeting ZNF674-AS1 expression in NB cells suppressed tumor growth in vivo. Further functional studies have revealed that ZNF674-AS1 constrains cisplatin sensitivity by suppressing pyroptosis and promoting cell proliferation. Moreover, ZNF674-AS1 primarily relies on CA9 to fulfill its functions on cisplatin resistance. High CA9 levels were associated with high-risk NB and predicted poor patient outcomes. Mechanistically, ZNF674-AS1 directly interacted with the RNA binding protein IGF2BP3 to enhance the stability of CA9 mRNA by binding with CA9 transcript, leading to elevated CA9 expression. As a novel regulator of CA9, IGF2BP3 positively upregulated CA9 expression. Together, these results expand our understanding of the cancer-associated function of lncRNAs, highlighting the ZNF674-AS1/IGF2BP3/CA9 axis as a constituting regulatory mode in NB tumor growth and cisplatin resistance. These insights reveal the pivotal role of ZNF674-AS1 inhibition in recovering cisplatin sensitivity, thus providing potential therapeutic targets for NB treatment.

26 February 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KZKunming Zhao
Kunming Zhao
XWXinyi Wang
Xinyi Wang
YJYaqiong Jin
Yaqiong Jin
XZXiaoxiao Zhu
Xiaoxiao Zhu
TZTao Zhou
Tao Zhou
DYDianke Yu
Dianke Yu